trial · primary record
SHR-A2009 + bevacizumab
Non-squamous Non-small Cell Lung Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 490 |
| Primary completion | 2030-12-30 |
| Primary endpoint | PFS |
| Registry ID | NCT07895992 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:44.852Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07895992
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.